Famotidine study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is needed

Share on facebook
Share with friends
Share on twitter
Tweet with friends

“Based on what we’ve learned in this study, it’s encouraging,” said Dr. Joseph Conigliaro, a coauthor of the paper and a physician at Northwell Health. “This association is actually really compelling.”

The drug, famotidine, has been on the market…

Others who read this also read

Scroll to Top